Antibody Responses to Melanoma/Melanocyte Autoantigens in Melanoma Patients
- 1 October 1998
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 111 (4), 662-667
- https://doi.org/10.1046/j.1523-1747.1998.00354.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Immunobiology of Human Melanoma Antigens MART-1 and gp100 and their Use for Immuno-Gene TherapyInternational Reviews of Immunology, 1997
- Tyrosinase and related proteins in mammalian pigmentationFEBS Letters, 1996
- Detection of β-human chorionic gonadotropin mRNA as a marker for cutaneous malignant melanomaInternational Journal of Cancer, 1996
- New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccinesMelanoma Research, 1996
- Peptide‐specific ctl in tumor‐infiltrating lymphocytes from metastatic melanomas expressing mart‐1/melan‐a, gp100 and tyrosinase genes: A study in an unselected group of hla‐a2.1‐positive patientsInternational Journal of Cancer, 1995
- Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigenMelanoma Research, 1995
- Cancer antigens: immune recognition of self and altered self.The Journal of Experimental Medicine, 1994
- Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma VaccineAnnals of Surgery, 1992
- Identification of Pigment Cell Antigens Defined by Vitiligo AntibodiesJournal of Investigative Dermatology, 1992
- A pigmentation‐associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serumInternational Journal of Cancer, 1983